Theme: Innovation in diabetes, the most cutting-edge technologies, and the latest research.
Herbal Diabetes 2022
We are pleased to announce the start of the "27th International Conference on Diabetes, Endocrinology, and Healthcare," which will be held in Tokyo, Japan on November 16-17, 2022 on the theme “Innovation in diabetes, the most cutting-edge technologies, and the latest research “. We invite all leading researchers, students, and delegates to attend Herbal Diabetes 2022 to participate in valuable scientific discussions and contribute to future innovations in medicine and polygenic disorder.
Join leading experts at this live event to learn about the state of diabetes care in 2022, as well as the most recent advances in research and treatment of complications.
Diabetes currently affects 138.2 million people in Asia, with the number expected to rise to 201.8 million by 2035
This conference will provide information on how the pandemic has affected Type 2 diabetes care, as well as the causal links between Covid and diabetes, the latest data on prevention and remission, and what the future holds for the treatment of complications in secondary care.
- Understand how Covid has changed the landscape of how Type-2 diabetes care is delivered
- Learn the latest information about the causal links between Covid and diabetes
- Explore the latest data on prevention and remission in the UK
- Gain updates on what’s new in in-patient care of diabetes
- Understand the latest developments in the research and treatment of a range of complications
- A live stream is also available for this event. Click here to register for the live stream.
Benefits of Attending
- Exchange ideas and a system with diabetologists, endocrinologists, polygenic disorder analysts, specialist clinicians, polygenic disorder and medicine consultants, and scientists from over forty countries
- Discuss cooperative approaches to deliver quality activities throughout the study of polygenic disorder and medicine and therefore the drawback and treatment of polygenic disorder
- Participants will increase guides' access to associate assembly centre of individuals from consultants and leaders and might broaden perception through rating and management of systems throughout conferences
- Learn and quote vital news and challenges with huge speakers.
- With introductions, governance dialogues, panel discussions and workshops, we tend to cowl each topic from begin to complete, from large-scale world problems to methodologies to strategic problems.
Diabetes Conference | Endocrinology Congress | Healthcare Meetings | Endocrinology Meetup | Pharma Conference | Pharmaceutical Conference | Therapeutic Substance | Top Diabetes Conference | Diabetes Congress | American Diabetes Association | Annual Clinical Conference on Diabetes
Track 1: Endocrine and Disorders
Our system includes eight major glands throughout your body, like the endocrine gland, endocrine, ductless gland, and exocrine gland. This technique affects growth and development, metabolism, sexual perform, and mood. If your internal secretion levels square measure too high or too low, you will have associate endocrine illness or disorder. Endocrine diseases and disorders additionally occur if your body doesn't answer hormones the manner it's speculated to.
Track 2:- Types of Diabetes
Diabetes may be a chronic (long-lasting) health condition that affects how your body turns food into energy. There are 3 main sorts of diabetes: type 1, type 2, and gestational diabetes (diabetes while pregnant. Type 1 is assumed to be caused by associate degree response reaction (the body attacks itself by mistake) that stops your body from creating insulin. With type 2, your body doesn’t use insulin well and can’t keep blood glucose at traditional levels. Gestational diabetes develops in pregnant ladies who haven't had earlier.
Track 3: Diabetes Mellitus
Diabetes is often thought to result due to an immune-associated, if not right away immune-mediated, destruction of insulin-producing duct gland duct gland cells.1, 2 traditionally, kind one disorder become mostly taken into thought an illness in youngsters and kids, but this opinion has changed throughout the last decade, just so age at symptomatic onset is not any longer a proscribing problem. 3 polyphagia and kidney disease on barefaced hyperglycaemia keep diagnostic hallmarks in children and children and to a lesser volume in adults.
Track 4: Diabetes Symptoms and Complications
Diabetes symptoms vary counting on what proportion your glucose is elevated. Some folks, particularly those with prediabetes or sort two diseases, might generally not expertise symptoms. In sort one diabetes, symptoms tend to come back on quickly and be additional severe. A number of the signs and symptoms of sort one diabetes and sort two disease are:
- Increased thirst
- Frequent urination
- Extreme hunger
- Unexplained weight loss
- Blurred vision
Track 5: Obesity and Metabolism for Diabetes
Obesity is a medical condition in which excess body fat has accumulated to the point where it is potentially harmful to one's health. High BMI is a risk factor for diet and physical activity-related diseases, but it is not a direct cause of them. Obesity is caused by a combination of individual, socioeconomic, and environmental factors. Diabetes and insulin resistance are strongly associated with BMI.
Track 6: Diabetic Retinopathy
Diabetic retinopathy is a condition that can occur in diabetics. It gradually deteriorates the retina, the light-sensitive lining at the back of the eye. Diabetic retinopathy is a potentially blinding complication of diabetes. Diabetes impairs the body's ability to utilise and store sugar. Too much sugar in the blood causes the disease, which can cause damage throughout the body, including the eye. When these tiny blood vessels leak blood and other fluids, diabetic retinopathy develops. The retinal tissue swells as a result, resulting in cloudy or blurred vision.
Track 7: Diabetic Nephropathy
Diabetic nephropathy is a severe complication of both type 1 and type 2diabetes. Diabetic kidney disease is another name for it. Diabetic nephropathy impairs the kidneys' ability to perform their normal function of removing waste products and excess fluid from the body. Maintaining a healthy lifestyle and properly managing your diabetes and high blood pressure are the best ways to prevent or delay diabetic nephropathy.
Track 8: Diabetic Nutrition and Diet
Medical nutrition therapy can help with both diabetes treatment and education. A diabetes diet is a low-fat, low-calorie eating plan that is high in nutrients. All fruits, vegetables, and whole grains must be consumed. In fact, a diabetes diet is the best eating plan for the vast majority of people. The plan aids in blood sugar control, weight management, and the management of risk factors for heart disease such as high blood pressure and high blood fats.
Track 9: Diabetes Etiology
In medicine, etiology is the process of determining the cause of a disease or condition. Diabetes has a disease-specific as well as a person-specific etiology. Diabetes is the result of a complex interplay of genetic, environmental, and lifestyle factors. The immune system destroys pancreatic cells, resulting in type 1 diabetes. Type 2 diabetes is characterised by insulin resistance and relative insulin insufficiency, which is frequently caused by a genetic predisposition.
Diabetes technology refers to the hardware, tools, and software that people with diabetes use to help them manage their blood glucose levels, avoid diabetes complications, lessen the burden of living with diabetes, and improve their quality of life. Traditionally, diabetes technology has been separated into two categories: insulin delivered via syringe, pen, or pump, and blood glucose monitoring via meter or continuous glucose monitor.
Track 11: Blood Glucose Dynamics and Monitoring
The determination of blood glucose levels is vital in the diagnosis and management of diabetes. Although individuals with diabetes have a great number of historical glucose measurements, there have been few data sets that have been recorded continuously or sampled frequently enough to reveal intrinsic blood glucose dynamics, or the change in blood glucose with time. As a result, blood sugar dynamics were rarely used in the diagnosis and treatment of diabetes.
Track 12: Emerging Treatments and Technologies
The impact of new therapies and technologies on health care includes numerous improvements to health outcomes, as well as an increase in cost and problems about access equality. New medicines, monitoring, and new healthcare enabling technology represent a once-in-a-generation potential to transform the lives of diabetics. These advancements allow for more accurate monitoring of blood glucose levels, as well as more precise insulin dose and administration.
Track 13: Nanotechnology in Diabetes Treatment
Nanotechnology has aided the development of innovative glucose testing and insulin administration mechanisms in diabetes research, which have the potential to significantly improve diabetics' quality of life. Nanomaterials, nanostructures, nanoparticle design, and their uses in humans are all part of this topic. It also provides more precise information for diabetes mellitus diagnosis.
Diabetes is a metabolic condition or a long-term condition in which blood sugar levels are too high. Diabetes is linked to a wide range of long-term complications, including blindness, heart and blood vessel disease, stroke, kidney failure, amputations, and nerve damage, to name a few. Prediabetes is a condition in which the blood sugar level is greater than normal. Although the level is not yet high enough to be classified as type 2 diabetes, people and children with prediabetes are more likely to acquire type-2 diabetes if they do not make lifestyle changes.
Track 15: Clinical Care and Education
Diabetes is a chronic illness that necessitates ongoing medical care and patient education in order to avoid acute complications and lower the risk of long-term problems. Diabetes management is complicated, and it necessitates addressing a variety of concerns in addition to glycaemic control. There is a substantial body of research that supports a variety of diabetes therapies. These standards of care are intended to provide physicians, patients, researchers, payers, and other interested parties with information about the components of diabetic care, treatment goals, and techniques for assessing care quality.
Patients with diabetes mellitus have a higher risk of developing coronavirus disease 2019 (COVID-19), which is caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 may potentially increase the risk of hyperglycemia in infected people. Hyperglycemia, in combination with other risk factors, may modulate immunological and inflammatory responses, predisposing individuals to severe COVID-19 and potentially fatal results. Patients with diabetes mellitus should be aware that COVID-19 can raise blood glucose levels, thus they should adhere to clinical guidelines for diabetes mellitus management more closely during the COVID-19 pandemic.
Track 17: Diabetes and Cardiology
Diabetes is a cardio metabolic disease that is characterized by inflammation. It raises practically every cardiovascular risk factor, and the majority of diabetics die from cardiac disease. However, recent clinical research findings combined with patient education provide new ways to enhance cardiovascular outcomes in diabetic patients. Diabetes and cardiovascular disease (CVD) have a complicated and multiple pathogenesis. Understanding these complex disease mechanisms can aid doctors in detecting and treating CVD in diabetic patients, as well as assisting patients in avoiding these potentially fatal consequences.
Track 18: Risks and Benefits of New Therapies
Individualization of care with careful medication selection is increasingly recognized as one of the foundations of care for diabetes, which is not a disease of "one size fits all." The amount of time spent in a condition of hyperglycemia has long been known to raise the risk of complications. Hyperglycemia can leave a negative "metabolic memory" on cells of the vasculature and target organs, encouraging the development of difficulties in the future.
Track 19: Transplantation and Artificial Pancreas
The pancreas is a digestive organ located behind the lower section of the stomach. Insulin, a hormone that regulates the absorption of sugar (glucose) into your cells, is one of its key activities. A pancreatic transplant is a surgical operation that involves transplanting a healthy pancreas from a deceased donor into a person who no longer has a functional pancreas. In medicine, a transplant is a section of tissue or an entire organ that is taken from its natural site and transplanted to a new location in the same person or in a different person.
Track 20: Insulin Resistance & Insulinotherapy
Insulin is a peptide hormone produced by the cells of the pancreatic islets of Langerhans that regulates blood glucose levels by aiding cellular glucose uptake, regulating carbohydrate, lipid, and protein metabolism, and encouraging cell division and proliferation through its mitagenic activities. Insulin resistance and its consequences are becoming more prominent as obesity and diabetes reach epidemic proportions in the developed world. Insulin resistance is described as a biological response that is diminished by a normal or elevated insulin level; traditionally, this refers to impaired sensitivity to insulin-mediated glucose disposal.
Track 21: Mental Health and Diabetes
A diabetes diagnosis might feel like a threat not only to one's health, but also to one's way of life, because managing diabetes necessitates modifications to one's daily routine. Blood sugar variations can cause a lot of anxiety. Blood sugar fluctuations can induce mood swings and other mental symptoms like weariness, difficulty thinking properly, and anxiety. Diabetes distress is a symptom that resembles stress, depression, and anxiety that is caused by having diabetes. Diabetes distress, unlike depression, can be traced back to diabetes-related causes.
“A discipline of computer science that tries to design systems or methods that analyses information and allow the handling of complexity in a wide range of applications,” is stated as AI. For efficient data handling and the development of tools and gadgets for diabetes care, AI is a viable and attractive option. Artificial intelligence (AI) is a rapidly evolving science, and its applications to diabetes, a global epidemic, have the potential to revolutionize the way diabetes is diagnosed and managed. Machine learning principles have been employed to build algorithms to support predictive models for the risk of diabetes and its complications.
Track 23: Global Diabetes Market
As a result of increased innovation and modernization of therapeutic treatments, the diabetes market has matured significantly during the last 20 years. Because the condition is so common, and patient numbers are likely to continue to rise in the near future, drug developers have found it to be a lucrative market. As a result, according to Global Data, a prominent data and analytics organization, the global market size, as measured by pharmaceutical sales, has expanded six fold since 2000. The global market for diabetes monitoring devices is expected to expand at a compound annual growth rate (CAGR) of 6.5 percent from $19.7 billion in 2020 to $27.0 billion in 2025.
Global Diabetes Market: is expected to grow at a CAGR of 7.6% for the forecast period of 2018-2023. The market is segmented on the basis of diabetes type, drug class, and diabetic devices. Devices for diabetics include blood glucose meters and insulin delivery devices. The blood glucose meter market will have the largest market share compared to insulin delivery systems such as syringes and pen injectors. Continuous blood glucose monitoring systems will see the fastest growth in the market.
The United States alone spends 11% of its health care expenditures on diabetes. India and China are most affected by diabetes with more than 120 million patients. The majority of diabetes patients are undiagnosed or do not have basic treatment. Some of the major manufacturers are trying to develop an artificial pancreas. Currently, CGMS devices are used with insulin pumps as a secondary prototype for the artificial pancreas. The artificial pancreas is expected to be ready for commercialization within the next decade.
Global Digital Diabetes/Management Market :
Expected to grow at a CAGR of 21.7% from 2018 to $12.03 billion by 2025. Increasing numbers of diabetes patients, increasing smartphone penetration, technological advancements in diabetes devices, and increasing funding for diabetes are the important factors in the growth of this market.
Based on The global digital diabetes management market is projected to reach $19.9 billion by 2024, up from $6.8 billion in 2019, at a CAGR of 23.8%.The growth of this market is mainly due to the increasing prevalence of diabetes, the increasing focus on the development and adoption of a digital platform for diabetes and technological progress.
Global Human Insulin Market:
Market Value Global Human Insulin is expected to register a CAGR of 8.8% over the 2018-2023 period, reflecting an increasing number of diabetes patients, a growing geriatric population, technological advancements in insulin delivery devices and increasing exposure of population for risk factors leading to diabetes.
Based on product, the human insulin market is divided into HI drugs and delivery devices. HI drugs had the largest market share in 2017, accounting for 79.5%, due to the high prevalence of diabetes, increased research and development (R&D) activities for drug discovery and development, growing market demand for HI analogues and increasing geriatric population. HI products are used in the treatment of type II diabetes, type I diabetes.
We provide the participants with different modes or ways to participate as Delegate or Speaker under either ACADEMIC / STUDENT / BUSINESS Category. The mode of participation is webinar through PowerPoint Presentation/ Video Presentation.
Keynote speaker: 45-50 minutes
Speaker (oral presentation): 25-30 minutes (only one person can present)
Speaker (workshop): 45-50 minutes (more than 1 can present)
Speaker (special session): 45-50 minutes (more than 1 can present)
Speaker (symposium): more than 45 minutes (more than 1 can present)
Delegate(only registration): will have access to all the sessions with all the benefits of registration
Poster presenter: can present a poster and enjoy the benefits of delegate
Remote attendance: can participate via video presentation or e-poster presentation
Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes
Attend Keynote Presentation by world’s most eminent researchers
Access to all the sessions
Get OCM certificate
Get worldwide acknowledgment to your profile and Research
Get your abstracts published with unique DOI in International Journals
Get up to 50% discounts for publishing your entire article in our open access International Journals
Get Handbooks and conference kits
Get an access to the network with eminent personalities from worldwide
- Diabetes: Advanced Technologies and Treatments
- Blood Glucose Dynamics and Monitoring
- Emerging Treatments and Technologies
- Prediabetes to Late-Stage Complicated Diabetes
- Clinical Care and Education
- COVID-19 and Diabetes, Post-COVID Diabetes
- Diabetes and Cardiology
- Global Diabetes Market
- Endocrine and Disorders
- Types of Diabetes
- Diabetes Mellitus
- Diabetes Symptoms and Complications
- Obesity and Metabolism for Diabetes
- Diabetic Retinopathy
- Diabetic Nephropathy
- Diabetic Nutrition and Diet
- Diabetes Etiology
- Nanotechnology in Diabetes Treatment
- Risks and Benefits of New Therapies
- Transplantation and Artificial Pancreas
- Insulin Resistance & Insulinotherapy
- Mental Health and Diabetes
- Artificial Intelligence: The Future for Diabetes Care
To share your views and research, please click here to register for the Conference.